Virus vs. superbug: first patient sought for groundbreaking lung infection trial
Disease control
Not yet recruiting
This is an early safety study for a single patient with a severe, antibiotic-resistant lung infection. It will test a new therapy that uses special viruses (called phages) designed to attack the bacteria, given alongside standard antibiotics. The goal is to see if this combinatio…
Phase: PHASE1 • Sponsor: Alberta Health services • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC